Irina Andreevna Bulavina
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Irina Andreevna Bulavina has a total of 40 co-authors. Here are the top co-authors by number of shared publications:
- Igor A. Khamnagadaev
Endocrinology Research Centre
6 shared publications - Ilya Leonidovich Ilyich
Endocrinology Research Centre
6 shared publications - Leonid A. Belousov
Endocrinology Research Centre
5 shared publications - Nataliya G. Mokrysheva
Endocrinology Research Centre, 117292 Moscow, Russia
5 shared publications - Aleksandr S. Zotov
Federal Scientific and Clinical Center for Specialized Medical Assistance and Medical Technologies of the Federal Medical Biological Agency
4 shared publications - Aleksandr V. Troitskiy
Federal Scientific and Clinical Center for Specialized Medical Care and Medical Technologies
4 shared publications
Latest Publications
- Open Access
- 31 May 2026
- Published by ECO-Vector LLC (Publications) in Journal of Clinical Practice
- Vol. 17 (2) , 179-186
Left ventricular summit cryoablation via the great cardiac vein for ventricular arrhythmias treatment: clinical cases
BackgroundClinical cases demonstrate the possibility of successful radical surgical treatment for ventricular arrhythmias originating from the left ventricle summit. Conventional transcatheter radiofrequency ablation may be contraindicated due to ablation area localization close to coronary arteries. Clinical Case Descriptions BackgroundThis clinical case series demonstrates the possibility of successful radical surgical treatment of ventricular arrhythmias arising from the left ventricular summit using cryoablation via the great cardiac vein. The standard approach for treating this arrhythmia involves transcatheter radiofrequency ablation, which may be contraindicated due to the close proximity of coronary arteries to the ablation site. ConclusionWhen the substrate of ventricular arrhytmia is localized in the the left ventricular summit, one of the optimal access routes for interventional treatment is the epicardial approach via the great cardiac vein. Catheter ablation in this area requires consideration of the coronary artery topology. If the arrhythmogenic substrate is in close proximity to the coronary vessels, cryoablation may be considered the optimal technique, providing both effectiveness and safety of the intervention.
- 31 May 2026
- Published by ECO-Vector LLC (Publications) in Journal of Clinical Practice
- Vol. 17 (2) , 179-186
Open AccessLeft ventricular summit cryoablation via the great cardiac vein for ventricular arrhythmias treatment: clinical cases
BackgroundClinical cases demonstrate the possibility of successful radical surgical treatment for ventricular arrhythmias originating from the left ventricle summit. Conventional transcatheter radiofrequency ablation may be contraindicated due to ablation area localization close to coronary arteries. Clinical Case Descriptions BackgroundThis clinical case series demonstrates the possibility of successful radical surgical treatment of ventricular arrhythmias arising from the left ventricular summit using cryoablation via the great cardiac vein. The standard approach for treating this arrhythmia involves transcatheter radiofrequency ablation, which may be contraindicated due to the close proximity of coronary arteries to the ablation site. ConclusionWhen the substrate of ventricular arrhytmia is localized in the the left ventricular summit, one of the optimal access routes for interventional treatment is the epicardial approach via the great cardiac vein. Catheter ablation in this area requires consideration of the coronary artery topology. If the arrhythmogenic substrate is in close proximity to the coronary vessels, cryoablation may be considered the optimal technique, providing both effectiveness and safety of the intervention.
- 11 February 2026
- Published by Endocrinology Research Centre in Diabetes mellitus
- Vol. 29 (1) , 57-58
Erratum: Rotary activity as the main electrophysiology mechanism of the persistent form of atrial fibrillation of patients with type 2 diabetes mellitus (Diabetes mellitus. 2025;28(6). doi: 10.14341/DM13412)
Erratum: "Rotary activity as the main electrophysiology mechanism of the persistent form of atrial fibrillation of patients with type 2 diabetes mellitus" by Irina A. Bulavina, Igor A. Khamnagadaev, Nikolay I. Tyurin, Ekaterina K. Melkozerova, Leonid A. Belousov, Irina Z. Bondarenko, Olga A. Shatskaya, Ilya L. Ilyich, Viktor Y. Kalashnikov published in Diabetes Mellitus. 2025;28(6):314-320. doi: 10.14341/DM13412.An error occurred in the author list of the original article: Natalia G. Mokrysheva was inadvertently omitted from the author list. The correct list of authors is as follows: Irina A. Bulavina, Igor A. Khamnagadaev, Nikolay I. Tyurin, Ekaterina K. Melkozerova, Leonid A. Belousov, Irina Z. Bondarenko, Olga A. Shatskaya, Ilya L. Ilyich, Viktor Y. Kalashnikov, Natalia G. Mokrysheva. The Editorial Office regrets this error. The original version of the article has been replaced.
- 11 February 2026
- Published by Endocrinology Research Centre in Diabetes mellitus
- Vol. 29 (1) , 57-58
Erratum: Rotary activity as the main electrophysiology mechanism of the persistent form of atrial fibrillation of patients with type 2 diabetes mellitus (Diabetes mellitus. 2025;28(6). doi: 10.14341/DM13412)
Erratum: "Rotary activity as the main electrophysiology mechanism of the persistent form of atrial fibrillation of patients with type 2 diabetes mellitus" by Irina A. Bulavina, Igor A. Khamnagadaev, Nikolay I. Tyurin, Ekaterina K. Melkozerova, Leonid A. Belousov, Irina Z. Bondarenko, Olga A. Shatskaya, Ilya L. Ilyich, Viktor Y. Kalashnikov published in Diabetes Mellitus. 2025;28(6):314-320. doi: 10.14341/DM13412.An error occurred in the author list of the original article: Natalia G. Mokrysheva was inadvertently omitted from the author list. The correct list of authors is as follows: Irina A. Bulavina, Igor A. Khamnagadaev, Nikolay I. Tyurin, Ekaterina K. Melkozerova, Leonid A. Belousov, Irina Z. Bondarenko, Olga A. Shatskaya, Ilya L. Ilyich, Viktor Y. Kalashnikov, Natalia G. Mokrysheva. The Editorial Office regrets this error. The original version of the article has been replaced.
- 17 January 2026
- Published by Endocrinology Research Centre in Diabetes mellitus
- Vol. 28 (6) , 533-540
Rotary activity as the main electrophysiology mechanism of the persistent form of atrial fibrillation of patients with type 2 diabetes mellitus
BACKGROUN D: treatment of patients with the persistent form of atrial fibrillation (AF) is an unsolved problem of the healthcare system due to a high risk of disability and mortality. Considering a low effectiveness of drug treatment for AF, intervention treatment (catheter ablation) is the main technology for eliminating trigger activity of pulmonary veins. The frequency of AF recurrence of patients with diabetes mellitus (DM) after surgery is higher than of patients without disorders of carbohydrate metabolism what could be explained with non-pulmonary vein triggers on the posterior wall of the left atrial (LA). Opportunities of preoperative diagnostic of non-pulmonary vein triggers of AF and personalization of catheter ablation reports of patients with DM has not been determined yet. AIM : to estimate an opportunity of preoperative diagnostic of rotor activities for personalization of catheter ablation reports of patients with the persistent form of AF and DM. MATERIALS AND METHODS : the study included 25 patients with persistent form of AF. Group 1: patients with DM aged 58–77. Group 2: patients without DM aged 38–76. To determine treatment tactics, all patients were made noninvasive electrophysiological mapping with the construction of a personalized virtual cardiac phantom. All patients were undergone interventional treatment. RESULTS : taking into account the identified localizations of rotor activity, the interventional treatment protocol was optimized: radiofrequency catheter isolation of PV was supplemented with focal (32%), linear (20%), and combined (focal+linear; 4%) radiofrequency effects. Extrapulmonary rotor activity was more common in patients with DM than in patients without diabetes. CONCLUSION : non-invasive electrophysiological mapping of the heart with the construction of a virtual heart phantom allows to verify rotor activity in the LA. In patients with diabetes type 2 and persistent AF rotor activity is more common than in patients without carbohydrate metabolism disorders (p<0.001). Personalization of the catheter ablation protocol in the left atrium based on rotor activity marked during pre-surgery examination helps to improve long-term results of maintaining sinus rhythm.ividual microRNAs involved in myocardial remodeling processes in young patients with type 1 diabetes mellitus.
- 17 January 2026
- Published by Endocrinology Research Centre in Diabetes mellitus
- Vol. 28 (6) , 533-540
Rotary activity as the main electrophysiology mechanism of the persistent form of atrial fibrillation of patients with type 2 diabetes mellitus
BACKGROUN D: treatment of patients with the persistent form of atrial fibrillation (AF) is an unsolved problem of the healthcare system due to a high risk of disability and mortality. Considering a low effectiveness of drug treatment for AF, intervention treatment (catheter ablation) is the main technology for eliminating trigger activity of pulmonary veins. The frequency of AF recurrence of patients with diabetes mellitus (DM) after surgery is higher than of patients without disorders of carbohydrate metabolism what could be explained with non-pulmonary vein triggers on the posterior wall of the left atrial (LA). Opportunities of preoperative diagnostic of non-pulmonary vein triggers of AF and personalization of catheter ablation reports of patients with DM has not been determined yet. AIM : to estimate an opportunity of preoperative diagnostic of rotor activities for personalization of catheter ablation reports of patients with the persistent form of AF and DM. MATERIALS AND METHODS : the study included 25 patients with persistent form of AF. Group 1: patients with DM aged 58–77. Group 2: patients without DM aged 38–76. To determine treatment tactics, all patients were made noninvasive electrophysiological mapping with the construction of a personalized virtual cardiac phantom. All patients were undergone interventional treatment. RESULTS : taking into account the identified localizations of rotor activity, the interventional treatment protocol was optimized: radiofrequency catheter isolation of PV was supplemented with focal (32%), linear (20%), and combined (focal+linear; 4%) radiofrequency effects. Extrapulmonary rotor activity was more common in patients with DM than in patients without diabetes. CONCLUSION : non-invasive electrophysiological mapping of the heart with the construction of a virtual heart phantom allows to verify rotor activity in the LA. In patients with diabetes type 2 and persistent AF rotor activity is more common than in patients without carbohydrate metabolism disorders (p<0.001). Personalization of the catheter ablation protocol in the left atrium based on rotor activity marked during pre-surgery examination helps to improve long-term results of maintaining sinus rhythm.ividual microRNAs involved in myocardial remodeling processes in young patients with type 1 diabetes mellitus.
- Open Access
- 26 December 2025
- Published by ECO-Vector LLC (Publications) in Cardiosomatics
- Vol. 16 (4) , 308-322
Clinical and epidemiological aspects of atrial fibrillation and/or atrial flutter in patients with diabetes mellitus: a cross-sectional retrospective population-based study
BACKGROUND: Diabetes mellitus (DM), atrial fibrillation (AF), and atrial flutter (AFL) are among the most prevalent cardiovascular disorders, with their incidence steadily increasing worldwide. The coexistence of DM with AF or AFL is associated with a more severe disease course and a less favorable prognosis compared with each condition occurring independently. AIM: To analyze current clinical and epidemiological aspects of atrial fibrillation (AF) and atrial flutter (AFL) in patients with diabetes mellitus, including sex- and age-related characteristics, distribution by subtype, and the relationship between diabetes mellitus and outcomes after radiofrequency catheter ablation. METHODS: A retrospective analysis of medical records was performed for patients hospitalized in the cardiology department of the National Medical Research Center for Endocrinology named after Academician I.I. Dedov (Moscow, Russia) between January 1, 2017, and October 30, 2025. RESULTS: Among the analyzed discharge summaries, 218 patients (24.9%) had type 2 diabetes mellitus. Of these patients, 30.7% had paroxysmal AF, 22.5% persistent AF, 15.1% persistent AF combined with AFL, 12.8% persistent AFL, 12.4% paroxysmal AF combined with AFL, and 6.5% paroxysmal AFL. Comparative analysis of patient groups with and without diabetes mellitus did not demonstrate convincing evidence of an effect of impaired carbohydrate metabolism on the outcomes of radiofrequency catheter ablation. CONCLUSION: This study clearly demonstrates the prevalence of diabetes mellitus among patients with AF and AFL and identifies criteria for further investigation of the impact of diabetes mellitus on the outcomes and progression of AF. Further study of this issue is required.
- 26 December 2025
- Published by ECO-Vector LLC (Publications) in Cardiosomatics
- Vol. 16 (4) , 308-322
Open AccessClinical and epidemiological aspects of atrial fibrillation and/or atrial flutter in patients with diabetes mellitus: a cross-sectional retrospective population-based study
BACKGROUND: Diabetes mellitus (DM), atrial fibrillation (AF), and atrial flutter (AFL) are among the most prevalent cardiovascular disorders, with their incidence steadily increasing worldwide. The coexistence of DM with AF or AFL is associated with a more severe disease course and a less favorable prognosis compared with each condition occurring independently. AIM: To analyze current clinical and epidemiological aspects of atrial fibrillation (AF) and atrial flutter (AFL) in patients with diabetes mellitus, including sex- and age-related characteristics, distribution by subtype, and the relationship between diabetes mellitus and outcomes after radiofrequency catheter ablation. METHODS: A retrospective analysis of medical records was performed for patients hospitalized in the cardiology department of the National Medical Research Center for Endocrinology named after Academician I.I. Dedov (Moscow, Russia) between January 1, 2017, and October 30, 2025. RESULTS: Among the analyzed discharge summaries, 218 patients (24.9%) had type 2 diabetes mellitus. Of these patients, 30.7% had paroxysmal AF, 22.5% persistent AF, 15.1% persistent AF combined with AFL, 12.8% persistent AFL, 12.4% paroxysmal AF combined with AFL, and 6.5% paroxysmal AFL. Comparative analysis of patient groups with and without diabetes mellitus did not demonstrate convincing evidence of an effect of impaired carbohydrate metabolism on the outcomes of radiofrequency catheter ablation. CONCLUSION: This study clearly demonstrates the prevalence of diabetes mellitus among patients with AF and AFL and identifies criteria for further investigation of the impact of diabetes mellitus on the outcomes and progression of AF. Further study of this issue is required.
- 17 February 2025
- Published by ECO-Vector LLC in Russian Medicine
- Vol. 31 (1) , 76-84
Obstructive sleep apnea in patients with bradyarrhythmias
BACKGROUND: Obstructive sleep apnea (OSA) is associated with various cardiovascular diseases, including arterial hypertension, chronic heart failure, and cardiac rhythm and conduction disorders. In some patients, preexisting bradycardia may not be directly related to OSA. Therefore, it is advisable to rule out OSA in patients referred for pacemaker implantation. CLINICAL CASES DESCRIPTION: OSA is a common condition frequently associated with bradyarrhythmias. In some cases, treatment for such patients involves the implantation of a permanent endocardial pacemaker. Undiagnosed OSA may lead to an increased number of unnecessary pacemaker implantations, emphasizing the importance of timely diagnosis and treatment of this condition. This article presents clinical observations of seven patients with nocturnal bradyarrhythmias, which resolved following continuous positive airway pressure (CPAP) therapy. The use of CPAP therapy contributed to the improvement of cardiovascular parameters, including the reduction in the number and duration of heart rhythm pauses. Clinically significant bradyarrhythmias were resolved in patients, allowing them to avoid surgical intervention. In the described cases, patients demonstrated a high apnea–hypopnea index (35.0–79.5 episodes per hour), a significant decrease in blood oxygen saturation (minimum up to 50%), and significant heart rhythm disturbances during the night. The initiation of CPAP therapy led to a reduction in the apnea–hypopnea index (1.9–23.1 episodes per hour), normalization of minimum oxygen saturation (80–93%), and the elimination of prolonged rhythm pauses. CONCLUSION: The findings highlight the necessity of mandatory screening for OSA in patients with nocturnal bradyarrhythmias before planning pacemaker implantation. CPAP therapy effectively eliminates rhythm disturbances associated with sleep apnea and prevents unnecessary surgical procedures. This confirms the importance of a comprehensive approach to the diagnosis and treatment of this category of patients and the need for further large-scale studies to optimize their management tactics.
- 17 February 2025
- Published by ECO-Vector LLC in Russian Medicine
- Vol. 31 (1) , 76-84
Obstructive sleep apnea in patients with bradyarrhythmias
BACKGROUND: Obstructive sleep apnea (OSA) is associated with various cardiovascular diseases, including arterial hypertension, chronic heart failure, and cardiac rhythm and conduction disorders. In some patients, preexisting bradycardia may not be directly related to OSA. Therefore, it is advisable to rule out OSA in patients referred for pacemaker implantation. CLINICAL CASES DESCRIPTION: OSA is a common condition frequently associated with bradyarrhythmias. In some cases, treatment for such patients involves the implantation of a permanent endocardial pacemaker. Undiagnosed OSA may lead to an increased number of unnecessary pacemaker implantations, emphasizing the importance of timely diagnosis and treatment of this condition. This article presents clinical observations of seven patients with nocturnal bradyarrhythmias, which resolved following continuous positive airway pressure (CPAP) therapy. The use of CPAP therapy contributed to the improvement of cardiovascular parameters, including the reduction in the number and duration of heart rhythm pauses. Clinically significant bradyarrhythmias were resolved in patients, allowing them to avoid surgical intervention. In the described cases, patients demonstrated a high apnea–hypopnea index (35.0–79.5 episodes per hour), a significant decrease in blood oxygen saturation (minimum up to 50%), and significant heart rhythm disturbances during the night. The initiation of CPAP therapy led to a reduction in the apnea–hypopnea index (1.9–23.1 episodes per hour), normalization of minimum oxygen saturation (80–93%), and the elimination of prolonged rhythm pauses. CONCLUSION: The findings highlight the necessity of mandatory screening for OSA in patients with nocturnal bradyarrhythmias before planning pacemaker implantation. CPAP therapy effectively eliminates rhythm disturbances associated with sleep apnea and prevents unnecessary surgical procedures. This confirms the importance of a comprehensive approach to the diagnosis and treatment of this category of patients and the need for further large-scale studies to optimize their management tactics.
- Open Access
- 18 January 2025
- Published by Endocrinology Research Centre in Diabetes mellitus
- Vol. 27 (6) , 572-579
Surgical approaches to maintaining sinus rhythm in patients with type 2 diabetes and long-term persistent atrial fibrillation
BACKGROUND: Treatment of patients with diabetes mellitus (DM) and a long-term persistent form of atrial fibrillation (AF) is an unsolved problem of the healthcare system due to a high risk of disability and mortality. Considering low effectiveness of drug treatment for AF, surgical technologies have been introduced into clinical practice in most countries, but their effectiveness has not been validated for patients with DM. According to various researches isolated interventional treatment of patients with AF and DM is associated with a high rate of recurrence compared to patients without disorders of carbohydrate metabolism. The feasibility of using other surgical approaches (the isolated thoracoscopic procedure or the isolated thoracoscopic procedure in combination with intracardiac intervention) for the treatment of AF for patients with DM has not been determined yet.AIM: To evaluate the effectiveness and safety of a staged surgical approach to release patients with DM from AF.MATERIALS AND METHODS: The study included 19 patients aged 53–73 with DM and long persistent AF. Among them there were 4 (21,4%) women and 15 (78,9%) men. To maintain sinus rhythm all patients were undergone with thoracoscopic epicardial ablation. In three mounts, later the invasive electrophysiological studies and radiofrequency ablation were carried out due to reconnection of left atrium (LA).RESULTS: At the end of the blinded period sinus rhythm was maintained for 17 (89,5%) patients during the observation period. Two patients (10.5%) had AF recurrence. In both cases, the second stage of treatment wasperformed (electrophysiology study and endocardial ablation). Amid normal sinus rhythm after thoracoscopic epicardial ablation the volume of the LA (p=0,013) and the N-terminal prohormone of brain natriuretic peptide (NT-proBNP) (p=0,014) significant decreased. No adverse events were recorded in the perioperative or long-term periods.CONCLUSION: Аccording to our pilot study, the staged approach to surgical maintenance of sinus rhythm for patients with diabetes and persistent form of atrial fibrillation can be an optimal strategy. The endocardial stage could be performed for this category of patients in case of recurrence of tachysystolic cardiac arrhythmias.
- 18 January 2025
- Published by Endocrinology Research Centre in Diabetes mellitus
- Vol. 27 (6) , 572-579
Open AccessSurgical approaches to maintaining sinus rhythm in patients with type 2 diabetes and long-term persistent atrial fibrillation
BACKGROUND: Treatment of patients with diabetes mellitus (DM) and a long-term persistent form of atrial fibrillation (AF) is an unsolved problem of the healthcare system due to a high risk of disability and mortality. Considering low effectiveness of drug treatment for AF, surgical technologies have been introduced into clinical practice in most countries, but their effectiveness has not been validated for patients with DM. According to various researches isolated interventional treatment of patients with AF and DM is associated with a high rate of recurrence compared to patients without disorders of carbohydrate metabolism. The feasibility of using other surgical approaches (the isolated thoracoscopic procedure or the isolated thoracoscopic procedure in combination with intracardiac intervention) for the treatment of AF for patients with DM has not been determined yet.AIM: To evaluate the effectiveness and safety of a staged surgical approach to release patients with DM from AF.MATERIALS AND METHODS: The study included 19 patients aged 53–73 with DM and long persistent AF. Among them there were 4 (21,4%) women and 15 (78,9%) men. To maintain sinus rhythm all patients were undergone with thoracoscopic epicardial ablation. In three mounts, later the invasive electrophysiological studies and radiofrequency ablation were carried out due to reconnection of left atrium (LA).RESULTS: At the end of the blinded period sinus rhythm was maintained for 17 (89,5%) patients during the observation period. Two patients (10.5%) had AF recurrence. In both cases, the second stage of treatment wasperformed (electrophysiology study and endocardial ablation). Amid normal sinus rhythm after thoracoscopic epicardial ablation the volume of the LA (p=0,013) and the N-terminal prohormone of brain natriuretic peptide (NT-proBNP) (p=0,014) significant decreased. No adverse events were recorded in the perioperative or long-term periods.CONCLUSION: Аccording to our pilot study, the staged approach to surgical maintenance of sinus rhythm for patients with diabetes and persistent form of atrial fibrillation can be an optimal strategy. The endocardial stage could be performed for this category of patients in case of recurrence of tachysystolic cardiac arrhythmias.
- Open Access
- 15 January 2025
- Published by Publishing House ABV Press in The Clinician
- Vol. 19 (1) , 29-38
Bradyarrhythmias in patients with obstructive sleep apnea
Aim. To compare patients with bradyarrhythmias and obstructive sleep apnea (OSA) and patients without OSA; to study the predictive capabilities of questionnaires in OSA screening.Material and methods. The study included 134 patients with bradyarrhythmias hospitalized for pacemaker implantation or pacemaker replacement. The median age was 67.5 years (interquartile range 59 to 72 years). Sleep apnea screening was performed using the Berlin questionnaire, the STOP-BANG sleep apnea risk scale, and the Epworth sleepiness scale. All patients underwent blood tests and instrumental examinations (respiratory monitoring and echocardiography).Results. Patients with OSA were older (68 years versus 64 years; p = 0.032), had a larger waist circumference (116 cm versus 108 cm; p = 0.044), and body mass index (33.7 kg/m2 versus 31.03 kg/m2; p = 0.016) compared to patients without OSA. The Berlin questionnaire (area under the curve (AUC) 0.79; sensitivity 92 %, specificity 38 %; p 0.0001) and the STOP-BANG risk scale (AUC 0.75; sensitivity 82 %, specificity 23 %; p 0.0001) had a high predictive power to identify sleep apnea while the Epworth sleepiness scale had a low predictive power (AUC 0.463; sensitivity 12 %, specificity 85 %). According to laboratory and instrumental data, patients with sleep apnea had significantly higher C-reactive protein levels (7.17 mg/L versus 1.73 mg/L; p = 0.012) and more frequently had interventricular septal hypertrophy (12 mm versus 10 mm; p = 0.02). Third-degree atrioventricular block was significantly more common in patients with sleep apnea (17.91 % versus 5.97 %; odds ratio 0.363; 95 % confidence interval 0.131–1.001; p = 0.045). In patients with sleep apnea, cardiac pacing for more than 5 years was more common (11.94 % versus 4.48 %; odds ratio 0.35; 95 % confidence interval 0.116–1.054; p = 0.049).Conclusion. High frequency of OSA was observed in patients with bradysystolic heart rate. The Berlin questionnaire and the STOP-BANG sleep apnea risk scale can be used to screen for OSA in patients with bradyarrhythmias. Elevated C-reactive protein levels and interventricular septal hypertrophy accentuate the importance of early diagnosis and treatment of OSA for improved prognosis.
- 15 January 2025
- Published by Publishing House ABV Press in The Clinician
- Vol. 19 (1) , 29-38
Open AccessBradyarrhythmias in patients with obstructive sleep apnea
Aim. To compare patients with bradyarrhythmias and obstructive sleep apnea (OSA) and patients without OSA; to study the predictive capabilities of questionnaires in OSA screening.Material and methods. The study included 134 patients with bradyarrhythmias hospitalized for pacemaker implantation or pacemaker replacement. The median age was 67.5 years (interquartile range 59 to 72 years). Sleep apnea screening was performed using the Berlin questionnaire, the STOP-BANG sleep apnea risk scale, and the Epworth sleepiness scale. All patients underwent blood tests and instrumental examinations (respiratory monitoring and echocardiography).Results. Patients with OSA were older (68 years versus 64 years; p = 0.032), had a larger waist circumference (116 cm versus 108 cm; p = 0.044), and body mass index (33.7 kg/m2 versus 31.03 kg/m2; p = 0.016) compared to patients without OSA. The Berlin questionnaire (area under the curve (AUC) 0.79; sensitivity 92 %, specificity 38 %; p 0.0001) and the STOP-BANG risk scale (AUC 0.75; sensitivity 82 %, specificity 23 %; p 0.0001) had a high predictive power to identify sleep apnea while the Epworth sleepiness scale had a low predictive power (AUC 0.463; sensitivity 12 %, specificity 85 %). According to laboratory and instrumental data, patients with sleep apnea had significantly higher C-reactive protein levels (7.17 mg/L versus 1.73 mg/L; p = 0.012) and more frequently had interventricular septal hypertrophy (12 mm versus 10 mm; p = 0.02). Third-degree atrioventricular block was significantly more common in patients with sleep apnea (17.91 % versus 5.97 %; odds ratio 0.363; 95 % confidence interval 0.131–1.001; p = 0.045). In patients with sleep apnea, cardiac pacing for more than 5 years was more common (11.94 % versus 4.48 %; odds ratio 0.35; 95 % confidence interval 0.116–1.054; p = 0.049).Conclusion. High frequency of OSA was observed in patients with bradysystolic heart rate. The Berlin questionnaire and the STOP-BANG sleep apnea risk scale can be used to screen for OSA in patients with bradyarrhythmias. Elevated C-reactive protein levels and interventricular septal hypertrophy accentuate the importance of early diagnosis and treatment of OSA for improved prognosis.
- Open Access
- 9 January 2024
- Published by Silicea - Poligraf, LLC in Russian Journal of Cardiology
- Vol. 29 (1) , 5604
Obstructive sleep apnea in bradyarrhythmias
In recent decades, there has been increased interest in obstructive sleep apnea (OSA), especially in patients with a combination of OSA and sleep bradyarrhythmias. Worldwide, the diagnosis of OSA is steadily increasing. Increasingly, clinicians have begun to use CPAP therapy to treat sleep-related bradyarrhythmias. But in world practice there are no unambiguous guidelines for the management of this group of patients.
- 9 January 2024
- Published by Silicea - Poligraf, LLC in Russian Journal of Cardiology
- Vol. 29 (1) , 5604
Open AccessObstructive sleep apnea in bradyarrhythmias
In recent decades, there has been increased interest in obstructive sleep apnea (OSA), especially in patients with a combination of OSA and sleep bradyarrhythmias. Worldwide, the diagnosis of OSA is steadily increasing. Increasingly, clinicians have begun to use CPAP therapy to treat sleep-related bradyarrhythmias. But in world practice there are no unambiguous guidelines for the management of this group of patients.
- Open Access
- 2 July 2023
- Published by ECO-Vector LLC in Journal of Clinical Practice
- Vol. 14 (2) , 5-18
Efficacy of two-stage approach for interventional treatment of coexistent atrial fibrillation and typical atrial flutter for sinus rhythm maintenance in long-term: a prospective controlled clinical trial
Background: Atrial fibrillation (AF) and coexistent typical atrial flutter (AFL) interventional treatment strategy remains unresolved in cardiology and cardiovascular surgery. Results of this approach remain suboptimal. There are several approaches to the interventional treatment of patients with coexistent AF and AFL: simultaneous pulmonary vein isolation (PVI) and cavotricuspid isthmus (CTI) radiofrequency catheter ablation (RFCA), PVI or CTI RFCA only and two-stage approach. To our knowledge, cumulative efficacy of two-stage approach has not been previously reported. The aim. This study aimed to evaluate the efficacy of two-stage approach for interventional treatment of coexistent AF and AFL for sinus rhythm maintenance in long-term. Methods: Patients (pts) (n=34) with AF and AFL aged 41–82 years (11 women) were divided into two groups (1:1): «One-stage Approach» (group 1; n=17): PVI+СTI RFСA and «Two-stage approach» (group 2; n=17): first stage — CTI RFCA (group 2.1); second stage — PVI in case of AF recurrence after RFCA (group 2.2). Primary endpoint (PEP) was defined as any recurrent atrial tachyarrhythmia at the end of follow-up; group 2 events have been considered after PVI. Secondary endpoint (SEP) — recurrent any atrial tachyarrhythmia in groups 1 and 2 after CTI RFCA in group 2. PEP and SEP were evaluated at the end of the «blind period» (3 months after procedure). Results: Registered recurrent atrial tachyarrhythmia in pts who reached PEP or SEP was AF. AFL has not been detected in any cases. PEP was noted in 8 (47.06%) pts in group 1 and 1 (5.88%) pts in group 2. Further, SEP was observed in 3 pts (17.65%) in group 1 and in 4 (23.53%) pts in group 2 (p=0.671). The probability of long-term maintenance of sinus rhythm was significantly higher in «Two-stage approach» than in «One-stage approach» (94.12% and 52.94%, respectively, p=0.001). Significant differences in procedure length and fluoroscopy time have been found. Those were longer in group 1 compared to group 2.1 (p 0.001) and in group 2.2 compared to group 2.1 (procedure duration — p 0.001; fluoroscopy time — p=0.013). No differences were noted in length of procedure and fluoroscopy time between groups 1 and 2.2 (p=0.374 and p=0.028, respectively). Conclusion: The «two-stage approach» for interventional treatment of coexistent AF and AFL results in better long-term arrhythmia-free survival than «one-stage approach» (94.12% and 52.94%, respectively, p=0.001). CTI RFCA alone in pts with coexistent AF and AFL cause 23.53% AF recurrence rate and associated with shorter procedure duration and fluoroscopy time compared to simultaneous PVI and CTI RFCA (p 0.001).
- 2 July 2023
- Published by ECO-Vector LLC in Journal of Clinical Practice
- Vol. 14 (2) , 5-18
Open AccessEfficacy of two-stage approach for interventional treatment of coexistent atrial fibrillation and typical atrial flutter for sinus rhythm maintenance in long-term: a prospective controlled clinical trial
Background: Atrial fibrillation (AF) and coexistent typical atrial flutter (AFL) interventional treatment strategy remains unresolved in cardiology and cardiovascular surgery. Results of this approach remain suboptimal. There are several approaches to the interventional treatment of patients with coexistent AF and AFL: simultaneous pulmonary vein isolation (PVI) and cavotricuspid isthmus (CTI) radiofrequency catheter ablation (RFCA), PVI or CTI RFCA only and two-stage approach. To our knowledge, cumulative efficacy of two-stage approach has not been previously reported. The aim. This study aimed to evaluate the efficacy of two-stage approach for interventional treatment of coexistent AF and AFL for sinus rhythm maintenance in long-term. Methods: Patients (pts) (n=34) with AF and AFL aged 41–82 years (11 women) were divided into two groups (1:1): «One-stage Approach» (group 1; n=17): PVI+СTI RFСA and «Two-stage approach» (group 2; n=17): first stage — CTI RFCA (group 2.1); second stage — PVI in case of AF recurrence after RFCA (group 2.2). Primary endpoint (PEP) was defined as any recurrent atrial tachyarrhythmia at the end of follow-up; group 2 events have been considered after PVI. Secondary endpoint (SEP) — recurrent any atrial tachyarrhythmia in groups 1 and 2 after CTI RFCA in group 2. PEP and SEP were evaluated at the end of the «blind period» (3 months after procedure). Results: Registered recurrent atrial tachyarrhythmia in pts who reached PEP or SEP was AF. AFL has not been detected in any cases. PEP was noted in 8 (47.06%) pts in group 1 and 1 (5.88%) pts in group 2. Further, SEP was observed in 3 pts (17.65%) in group 1 and in 4 (23.53%) pts in group 2 (p=0.671). The probability of long-term maintenance of sinus rhythm was significantly higher in «Two-stage approach» than in «One-stage approach» (94.12% and 52.94%, respectively, p=0.001). Significant differences in procedure length and fluoroscopy time have been found. Those were longer in group 1 compared to group 2.1 (p 0.001) and in group 2.2 compared to group 2.1 (procedure duration — p 0.001; fluoroscopy time — p=0.013). No differences were noted in length of procedure and fluoroscopy time between groups 1 and 2.2 (p=0.374 and p=0.028, respectively). Conclusion: The «two-stage approach» for interventional treatment of coexistent AF and AFL results in better long-term arrhythmia-free survival than «one-stage approach» (94.12% and 52.94%, respectively, p=0.001). CTI RFCA alone in pts with coexistent AF and AFL cause 23.53% AF recurrence rate and associated with shorter procedure duration and fluoroscopy time compared to simultaneous PVI and CTI RFCA (p 0.001).
- Open Access
- 11 April 2023
- Published by ECO-Vector LLC in Journal of Clinical Practice
- Vol. 14 (1) , 101-107
Anticoagulation after typical atrial flutter ablation
The specifics of the anticoagulant therapy after radiofrequency ablation of the cavotricuspid isthmus have not been sufficiently studied, therefore, the recommendations for prescribing the anticoagulant therapy usually do not distinguish between atrial flutter and atrial fibrillation. In contrast to the case of atrial fibrillation, the effectiveness of the interventional treatment for typical atrial flutter reaches 90%. This procedure may save the patient from a long-term anticoagulant therapy in the absence of recurrence of typical atrial flutter. The decision to stop the anticoagulant therapy after successful radiofrequency ablation of the cavotricuspid isthmus should take into account the potential induction of atrial fibrillation in patients undergoing the interventional treatment. In addition to the CHA2DS2-VASc scale, which characterizes the patient's comorbidity, it is important to take into account the echocardiographic morphofunctional criteria to assess the risk of atrial fibrillation. Currently, this protocol is not regulated in the clinical guidelines. The analysis of the literature data and the authors' own experience allow us to conclude that the optimal time for stopping the anticoagulant therapy is a relapse-free period of 34 months after the radiofrequency ablation of the cavotricuspid isthmus, since it is at this time that the effectiveness of the interventional treatment can be objectified.
- 11 April 2023
- Published by ECO-Vector LLC in Journal of Clinical Practice
- Vol. 14 (1) , 101-107
Open AccessAnticoagulation after typical atrial flutter ablation
The specifics of the anticoagulant therapy after radiofrequency ablation of the cavotricuspid isthmus have not been sufficiently studied, therefore, the recommendations for prescribing the anticoagulant therapy usually do not distinguish between atrial flutter and atrial fibrillation. In contrast to the case of atrial fibrillation, the effectiveness of the interventional treatment for typical atrial flutter reaches 90%. This procedure may save the patient from a long-term anticoagulant therapy in the absence of recurrence of typical atrial flutter. The decision to stop the anticoagulant therapy after successful radiofrequency ablation of the cavotricuspid isthmus should take into account the potential induction of atrial fibrillation in patients undergoing the interventional treatment. In addition to the CHA2DS2-VASc scale, which characterizes the patient's comorbidity, it is important to take into account the echocardiographic morphofunctional criteria to assess the risk of atrial fibrillation. Currently, this protocol is not regulated in the clinical guidelines. The analysis of the literature data and the authors' own experience allow us to conclude that the optimal time for stopping the anticoagulant therapy is a relapse-free period of 34 months after the radiofrequency ablation of the cavotricuspid isthmus, since it is at this time that the effectiveness of the interventional treatment can be objectified.